RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report

Personalized medicine using molecular-targeted drugs to achieve better therapeutic response and long-term prognosis is common practice for lung cancer treatment. However, in cases before gene batch tests were available, medical treatment continued without the detection of rare mutations. We report a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Kei, Handa, Hiroshi, Ueno, Junko, Tsuruoka, Hajime, Inoue, Takeo, Shimada, Naoki, Koike, Junki, Nakamura, Seiji, Sato, Yoshiharu, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702555/
https://www.ncbi.nlm.nih.gov/pubmed/36452495
http://dx.doi.org/10.3389/fonc.2022.1019932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702555/
https://www.ncbi.nlm.nih.gov/pubmed/36452495
http://dx.doi.org/10.3389/fonc.2022.1019932

Ejemplares similares